Sulforaphane rescues memory dysfunction and synaptic and mitochondrial alterations induced by brain iron accumulation

Area of Science:

• Neuroscience
• Mitochondrial Biology
• Neuroprotection

Background:

• Iron overload exacerbates neurodegeneration and apoptosis via reactive oxygen species (ROS) production.
• Mitochondria are key sources of ROS and targets of oxidative damage, influencing cellular health.
• Mitochondrial dynamics (fusion and fission) are crucial for cellular adaptation and energy homeostasis.

Purpose of the Study:

• To investigate the neuroprotective effects of Sulforaphane (SFN) against iron-induced cognitive deficits.
• To examine SFN's impact on mitochondrial function markers (DNM1L, OPA1) and synaptic integrity (synaptophysin) in an iron-overload rat model.

Main Methods:

• Neonatal rats received carbonyl iron or vehicle, followed by adult treatment with saline or SFN.
• Cognitive function was assessed using the object recognition task.
• Hippocampal levels of DNM1L, OPA1, and synaptophysin were quantified via Western blotting.

Main Results:

• SFN treatment reversed iron-induced recognition memory impairment.
• SFN normalized decreased levels of the mitochondrial fission protein DNM1L.
• SFN restored reduced synaptophysin levels in the hippocampus.

Conclusions:

• SFN ameliorates cognitive deficits associated with neonatal iron overload.
• SFN's protective effects involve the modulation of mitochondrial dynamics and synaptic protein expression.
• SFN shows potential as a therapeutic agent for neurodegenerative conditions involving cognitive decline.